Work

GABAergic and Glutamatergic Deficits in Schizophrenia: Pathophysiological Mechanisms Underlying Negative Symptoms and Cognitive Impairment

Year: 2026
Type: article
Abstract: Schizophrenia is a complex neurodevelopmental disorder characterized by positive, negative, and cognitive symptoms. While classical dopaminergic models explain psychotic features, they fail to address the debilitating negative and cognitive deficits that dictate long-term disability. We aim to synthesize contemporary evidence on the impairment of the excitatory/inhibitory (E/I) balance within cortical microcircuits as a central pathophysiological hypothesis of the disorder. The cascade is hypothesized to be driven by N-methyl-D-aspartate (NMDA) receptor hypofunction, which impairs parvalbumin-positive (PV+) interneurons and consequently downregulates glutamic acid decarboxylase (GAD67)-mediated gamma-aminobutyric acid (GABA) synthesis. Weakened PV+ interneuron function disrupts Pyramidal-Interneuron Network Gamma (PING) dynamics, reducing gamma-band synchronization and fronto-temporo-thalamic connectivity. At the macroscopic and cellular levels, the E/I imbalance is linked to reduced neuropil volume and aberrant synaptic pruning that disturbs dendritic architecture. Clinically, this triggers severe working memory dysfunction, cognitive rigidity, avolition, and anhedonia. This paper presents emerging glutamatergic and GABAergic pharmacological strategies, including glycine, D-serine, and metabotropic glutamate receptor (mGluR) modulators. We highlight key directions for future research, emphasizing the use of translational biomarkers (e.g., mismatch negativity (MMN), magnetic resonance spectroscopy (MRS), and gamma oscillations) to normalize PV+ interneuron function and network-level synchronization.
Language: English
Field: Medicine
Open Access status: gold
Estimated APC paid: $3,499
OpenAlex ID: W7235428970
FWCI:
Cites: 143
Cited by:
Related to: 10